Drug Updates

Drug updates provide the latest information and relevant warnings and notifications.

Update on Drugs and Drug News: September 2010

Update on drugs, approval dates, and comments. Velaglucerase alfa (VPRIV®) and Health Canada labelling changes for isopropyl myristate 50% rinse (Resultz®, Nycomed) to include the treatment of lice in children =2 years of age are covered.

Update on Drugs and Drug News: March 2011

Update on drugs, approval dates, and comments. Spinosad 0.9% cream rinse (Natroba™), Light emitting diode (LED) skin rejuvenation system (Tanda™ Professional Rejuvenate), Voclosporin Voclera™ (ISA247) are covered.

Update on Drugs and Drug News – December 2006 – January 2007

Update on Polymethylmethacrylate/ Bovine Collagen ArteFill® Artes Medical, Polyphenon® E Ointment 15% MediGene AG/ Bradley Pharmaceuticals, and drug news on melanoma and new vaccines.

Update on Drugs and Drug News: January 2000

Update on: Pyrethrins/Piperonyl butoxide Rid aerosol foam mousse Fluocinolone acetonide 0.01% Derma-Smoothe/FS Quinupristin/ Dalfopristin Synercid IV Rid Lice Egg Loosener Gel Tacrolimus Protopic Ointment Docosanol

Update on Drugs and Drug News – February 2006

Update on Doxycycline Oracea® CollaGenex, Hydrogel Dressing MimyX™ Cream Stiefel Laboratories, and Aluma™ Skin Renewal System with FACES™ Lumenis.

Update on Drugs and Drug News: April 2012

Update on drugs, approval dates, and comments. Ivermectin 0.5% lotion (Sklice™), Ipilimumab (Yervoy™), Vemurafenib (Zelboraf®), are covered, as well as the Cellulite removal laser device Cellulaze™ Cellulite Laser Workstation.

Update on Drugs and Drug News: May 2001

Update on: Moxifloxacin HCl Avelox Recombinant Human Iduronidase (IDUA) Neurotoxins Botox Graftskin Apligraf

Update on Drugs and Drug News – March 2007

Update on Diclofenac Sodium 3% Gel Solaraze®, Retapamulin Ointment 1% Altabax™, Calcium Hydroxylapatite Microspheres in Water-based Gel Radiesse®, Rose Bengal Disodium 10% PV-10, and Taxane Potentiator STA-4783.

Update on Drugs and Drug News: February 2009

Update on Alitretinoin (Toctino®), Denileukin Diftitox (Ontak™), Bimatoprost Ophthalmic 0.03% Solution (LATISSE®), Maraviroc (SELZENTRY®), Clindamycin Phosphate 1.2% + Benzoyl Peroxide 2.5% (Acanya® Gel), Etanercept (Enbrel®).

Update on Drugs and Drug News: December 2001

Update on: Tazarotene 0.1% Tazorac® Botulinum Toxin BOTOX® Tacrolimus Ointment Protopic® Amlexanox 5% paste Aptheal® Tenofovir Disoproxil Fumarate Viread™ HIV Drug Resistance Test Trugene™ HIV-1 Genotyping Test

Update on Drugs and Drug News – December 2007 – January 2008

Update on Loratadine Dry Syrup 1% Claritin® Schering-Plough, Valacyclovir Hydrochloride TEVA Pharmaceutical Industries, and news about Anti-dandruff, anti-acne and anti-melanoma agents.

Update on Drugs & Devices: November-December 2021

The update covers Difelikefalin for IV use - Korsuva™ (Vifor Pharma, Cara Therapeutics), Topical MEK inhibitor - NFX-179 (NFlextion Therapeutics), Maralixibat oral solution - Livmarli™ (Mirum Pharmaceuticals), Ruxolitinib cream 1.5% - Opzelura™ (Incyte), Ruxolitinib tablets - Jakafi® (Incyte), and Avacopan capsules - Tavneos™ (ChemoCentryx).

Update on Drugs & Devices: January-February 2022

Drug update covering: Adalimumab-adbm for SC use - Cyltezo®, Tralokinumab for SC use - Adtralza® (in Canada), Tralokinumab-ldrm for SC use - Adbry™ (in US), Melanoma vaccine for IV use - BNT111, Adalimumab-aqvh for SC use - Yusimry™, and more...

Update on Drugs and Drug News: June 2009

Update on Golimumab (Simponi™) Centocor/Schering-Plough, Darunavir (PREZISTA™) Tibotec/Janssen-Ortho, Telavancin (Arbelic™) Theravance/Astellas, and news from US FDA.

Update on Drugs and Drug News: January 2010

Update on Capsaicin 8% Patch Qutenza™, Alitretinoin Capsule Toctino® as well as news about a recent study by Kenter et al.* explored the efficacy of a human papillomavirus (HPV) vaccine.

Update on Drugs & Devices: May-June 2022

This update covers Nivolumab + Relatlimab-rmbw for IV use - Opdualag™ (Bristol-Myers Squibb), Sirolimus topical gel 0.2% - Hyftor™ (Nobelpharma America), Oral epinephrine - AQST-109 (Aquestive Therapeutics), and Bimekizumab for SC use - Bimzelx® (UCB Canada Inc.).

Update on Drugs & Devices: March-April 2022

This update covers Adalimumab biosimilar - Yuflyma™ (Celltrion Healthcare), Adalimumab biosimilar - Simlandi™ (Alvotech/JAMP Pharma), Abrocitinib tablet - Cibinqo® (Pfizer), Upadacitinib tablet - Rinvoq® (AbbVie), Risankizumab-rzaa SC injection - Skyrizi® (AbbVie), and HA-based dermal filler - Juvéderm® Volbella® XC (AbbVie/ Allergan Aesthetics).

POPULAR